{"schema_version":"secwatch.filing_event.v1","accession":"0001185185-22-001369","form_type":"8-K","ticker":"BHIC","cik":"0001784440","company_name":"BioScience Health Innovations, Inc.","filed_at":"2022-11-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:52.103113+00:00","generated_at":"2026-06-21T12:22:41.471287+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Nowtransit sells 40,000 Series A convertible preferred shares for $40,000 gross proceeds","bullets":["Sold 40,000 Series A convertible preferred shares at $1.00/share to an accredited investor, raising $40,000 gross before expenses.","Each Series A share converts into 3 shares of common stock at holder's election, subject to 4.99% beneficial ownership limitation.","The 4.99% limitation may be increased to 9.99% upon 61 days' notice.","Proceeds will be used for working capital and general corporate purposes (implied)."],"urls":{"canonical":"https://secwatch.observer/filing/0001185185-22-001369","json":"https://secwatch.observer/filing/0001185185-22-001369.json","markdown":"https://secwatch.observer/filing/0001185185-22-001369.md","text":"https://secwatch.observer/filing/0001185185-22-001369.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1784440/000118518522001369/0001185185-22-001369-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1784440/000118518522001369/nowtransit20221129_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T12:22:41.471287+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5c811b948047becd4d256867ad01e88c5ae07bf2","claim":"BioScience Health Innovations, Inc. entered into Stock Purchase Agreement with an accredited investor valued at $40,000 (effective 2022-11-22).","evidence_excerpt":"On November 22, 2022, Nowtransit Inc. (the “Company”) entered into a Stock Purchase Agreement (the “Agreement”) with an accredited investor pursuant to which the Company sold to the purchaser 40,000 shares of the Company’s Series A Convertible Preferred Stock (the “Series A”) at a purchase price of $1.00 per share (the “Offering”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1784440/000118518522001369/0001185185-22-001369-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"an accredited investor"},{"label":"Value","value":"$40,000"},{"label":"Effective","value":"2022-11-22"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}